SCHEMBL19211635

SCHEMBL19211635

O=c1[nH]c(=O)c2[nH]c(-c3ccccc3S(=O)(=O)O)nc2[nH]1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2B P29275 4/20 0.57
▸ XDH P47989 3/20 0.43
▸ ALDH1A1 P00352 3/20 0.39
▸ HSD17B10 Q99714 3/20 0.39
▸ HPGD P15428 3/20 0.39
▸ ALOX15 P16050 2/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ ADORA2A P29274 3/20 0.37
▸ KDM4E B2RXH2 3/20 0.37
▸ BLM P54132 2/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ PABPC1 P11940 1/20 0.37
▸ CASP7 P55210 1/20 0.37
▸ PMP22 Q01453 1/20 0.37
▸ ADORA3 P0DMS8 1/20 0.37
▸ ADORA1 P30542 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6796628 0.75 ADORA2B (0.64) ADORA2BXDHALDH1A1HSD17B10HPGD
SCHEMBL378879 0.73 ADORA2B (1.00) ADORA2BXDHALDH1A1HPGDADORA2A
SCHEMBL29600264 0.70 MAPT (0.47) ADORA2BXDHALDH1A1HSD17B10HPGD
SCHEMBL18036538 0.69 ADORA2B (0.63) ADORA2BXDHALDH1A1HSD17B10HPGD
Alloxazine SCHEMBL12484288 0.69 BLM (0.62) ADORA2BALDH1A1HSD17B10ADORA2AKDM4E
SCHEMBL19233007 0.68 KDM4E (0.47) ALDH1A1HSD17B10HPGDALOX15MAPK1
SCHEMBL10691998 0.66 ADORA2B (0.42) ADORA2BALDH1A1HSD17B10HPGDALOX15
SCHEMBL458284 0.66 SMN1; SMN2 (0.48) MAPK1KDM4EBLMRAB9ACYP1A2
SCHEMBL9253425 0.66 ADORA2B (0.59) ADORA2BALDH1A1HSD17B10HPGDMAPK1
SCHEMBL23607984 0.65 ADORA2B (0.71) ADORA2BXDHALDH1A1HPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017137528-A1 ADENOSINE A1 RECEPTOR AGONIST FOR USE IN TREATMENT OF STATUS EPILEPTICUS CHARITÉ - UNIVERSITÄTSMEDIZIN BERLIN (DE) 2017-08-17 — — WO disclosed
Send feedback